Exercise Intolerance in Pulmonary Arterial Hypertension

Chen, L. W., Chen, S. Y., Hsu, H. H., Wu, Y. W., Lai, Y. M., & Chien, M. Y. (2021). Exercise Capacity and Quality of Life in Pulmonary Arterial Hypertension. Acta Cardiologica Sinica, 37(1), 74-85. https://doi.org/10.6515/ACS.202101_37(1).20200720A
許志新（2016）。The Update of Drugs for Pulmonary Arterial Hypertension。台灣醫學，20(2)，158-166。https://doi.org/10.6320/FJM.2016.20(2).5
林蕙鈴、謝慧觀（2014）。Inhaled Drug Therapy for Patients with Pulmonary Arterial Hypertension。呼吸治療，13(1)，13-24。https://doi.org/10.6269/JRT.2014.13.1.02
Hsu, C. H., Glassner, C., Hsu, H. H., & Maitland, M. G. (2012). Current Therapeutics for Pulmonary Arterial Hypertension. Acta Cardiologica Sinica, 28(4), 267-278. https://www.airitilibrary.com/Article/Detail?DocID=10116842-201212-201301210008-201301210008-267-278
李慧媛（1989）。Exercise in Patients with Chronic Obstructive Pulmonary Disease。中華民國物理治療學會雜誌，14()，8-15。https://doi.org/10.29616/JPTAROC.198910.0002